{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T15:10:55Z","timestamp":1793373055184,"version":"4.5.0"},"reference-count":175,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003180","name":"Academic Medical Center","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003180","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rev Endocr Metab Disord"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1007\/s11154-018-9448-1","type":"journal-article","created":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T00:37:24Z","timestamp":1529455044000},"page":"93-106","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":306,"title":["Disorders of mitochondrial long-chain fatty acid oxidation and the carnitine shuttle"],"prefix":"10.1007","volume":"19","author":[{"given":"Suzan J. G.","family":"Knottnerus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette C.","family":"Bleeker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob C. I.","family":"W\u00fcst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha","family":"Ferdinandusse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lodewijk","family":"IJlst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits A.","family":"Wijburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald J. A.","family":"Wanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gepke","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9961-0842","authenticated-orcid":false,"given":"Riekelt H.","family":"Houtkooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,20]]},"reference":[{"issue":"1","key":"9448_CR1","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1152\/physrev.00015.2009","volume":"90","author":"GD Lopaschuk","year":"2010","unstructured":"Lopaschuk GD, et al. Myocardial fatty acid metabolism in health and disease. Physiol Rev. 2010;90(1):207\u201358.","journal-title":"Physiol Rev"},{"issue":"3","key":"9448_CR2","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1046\/j.1432-1033.2003.03947.x","volume":"271","author":"K Bartlett","year":"2004","unstructured":"Bartlett K, Eaton S. Mitochondrial \u03b2-oxidation. Eur J Biochem. 2004;271(3):462\u20139.","journal-title":"Eur J Biochem"},{"key":"9448_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1146\/annurev-nutr-071813-105541","volume":"34","author":"TJ Grevengoed","year":"2014","unstructured":"Grevengoed TJ, Klett EL, Coleman RA. Acyl-CoA metabolism and partitioning. Annu Rev Nutr. 2014;34:1\u201330.","journal-title":"Annu Rev Nutr"},{"issue":"2","key":"9448_CR4","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1007\/s00239-009-9263-0","volume":"69","author":"Z Swigonova","year":"2009","unstructured":"Swigonova Z, Mohsen AW, Vockley J. Acyl-CoA dehydrogenases: dynamic history of protein family evolution. J Mol Evol. 2009;69(2):176\u201393.","journal-title":"J Mol Evol"},{"issue":"5","key":"9448_CR5","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1007\/s10545-010-9104-8","volume":"33","author":"RJ Wanders","year":"2010","unstructured":"Wanders RJ, et al. The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results. J Inherit Metab Dis. 2010;33(5):479\u201394.","journal-title":"J Inherit Metab Dis"},{"issue":"8","key":"9448_CR6","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.bbalip.2009.05.006","volume":"1791","author":"M Chegary","year":"2009","unstructured":"Chegary M, et al. Mitochondrial long chain fatty acid beta-oxidation in man and mouse. Biochim Biophys Acta. 2009;1791(8):806\u201315.","journal-title":"Biochim Biophys Acta"},{"issue":"7","key":"9448_CR7","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1203\/00006450-198507000-00006","volume":"19","author":"Daniel E Hale","year":"1985","unstructured":"Hale DE, Batshaw ML, Coates PM, Frerman FE, Goodman SI, Singh I, et al. Long-chain acyl coenzyme a dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatr Res. 1985;19(7):666\u201371.","journal-title":"Pediatric Research"},{"issue":"3","key":"9448_CR8","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1203\/00006450-199109000-00001","volume":"30","author":"Y Indo","year":"1991","unstructured":"Indo Y, Coates PM, Hale DE, Tanaka K. Immunochemical characterization of variant long-chain acyl-CoA dehydrogenase in cultured fibroblasts from nine patients with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res. 1991;30(3):211\u20135.","journal-title":"Pediatr Res"},{"issue":"1","key":"9448_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1203\/00006450-199307000-00025","volume":"34","author":"S Yamaguchi","year":"1993","unstructured":"Yamaguchi S, Indo Y, Coates PM, Hashimoto T, Tanaka K. Identification of very-long-chain acyl-CoA dehydrogenase deficiency in three patients previously diagnosed with long-chain acyl-CoA dehydrogenase deficiency. Pediatr Res. 1993;34(1):111\u20133.","journal-title":"Pediatr Res"},{"issue":"5","key":"9448_CR10","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s10545-010-9061-2","volume":"33","author":"SM Houten","year":"2010","unstructured":"Houten SM, Wanders RJ. A general introduction to the biochemistry of mitochondrial fatty acid beta-oxidation. J Inherit Metab Dis. 2010;33(5):469\u201377.","journal-title":"J Inherit Metab Dis"},{"key":"9448_CR11","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1146\/annurev-physiol-021115-105045","volume":"78","author":"SM Houten","year":"2016","unstructured":"Houten SM, Violante S, Ventura FV, Wanders RJA. The biochemistry and physiology of mitochondrial fatty acid beta-oxidation and its genetic disorders. Annu Rev Physiol. 2016;78:23\u201344.","journal-title":"Annu Rev Physiol"},{"issue":"2","key":"9448_CR12","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1093\/jn\/124.2.165","volume":"124","author":"H Schulz","year":"1994","unstructured":"Schulz H. Regulation of fatty acid oxidation in heart. J Nutr. 1994;124(2):165\u201371.","journal-title":"J Nutr"},{"issue":"4","key":"9448_CR13","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1002\/jnr.490180407","volume":"18","author":"J Edmond","year":"1987","unstructured":"Edmond J, Robbins RA, Bergstrom JD, Cole RA, de Vellis J. Capacity for substrate utilization in oxidative metabolism by neurons, astrocytes, and oligodendrocytes from developing brain in primary culture. J Neurosci Res. 1987;18(4):551\u201361.","journal-title":"J Neurosci Res"},{"issue":"3","key":"9448_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1111\/jnc.14072","volume":"142","author":"JN Jernberg","year":"2017","unstructured":"Jernberg JN, Bowman CE, Wolfgang MJ, Scafidi S. Developmental regulation and localization of carnitine palmitoyltransferases (CPTs) in rat brain. J Neurochem. 2017;142(3):407\u201319.","journal-title":"J Neurochem"},{"issue":"6","key":"9448_CR15","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1203\/01.PDR.0000161413.42874.74","volume":"57","author":"NA Oey","year":"2005","unstructured":"Oey NA, et al. Long-chain fatty acid oxidation during early human development. Pediatr Res. 2005;57(6):755\u20139.","journal-title":"Pediatr Res"},{"issue":"4115","key":"9448_CR16","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1126\/science.182.4115.929","volume":"182","author":"S DiMauro","year":"1973","unstructured":"DiMauro S, DiMauro PMM. Muscle carnitine Palmityltransferase deficiency and Myoglobinuria. Science. 1973;182(4115):929\u201331.","journal-title":"Science"},{"issue":"2","key":"9448_CR17","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0021-9258(18)48390-1","volume":"267","author":"K Izai","year":"1992","unstructured":"Izai K, Uchida Y, Orii T, Yamamoto S, Hashimoto T. Novel fatty acid beta-oxidation enzymes in rat liver mitochondria. I. Purification and properties of very-long-chain acyl-coenzyme a dehydrogenase. J Biol Chem. 1992;267(2):1027\u201333.","journal-title":"J Biol Chem"},{"issue":"1","key":"9448_CR18","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.25.1.16","volume":"25","author":"G Karpati","year":"1975","unstructured":"Karpati G, et al. The syndrome of systemic carnitine deficiency. Clinical, morphologic, biochemical, and pathophysiologic features. Neurology. 1975;25(1):16\u201324.","journal-title":"Neurology"},{"issue":"3","key":"9448_CR19","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/0006-291X(92)91350-Y","volume":"188","author":"RJ Wanders","year":"1992","unstructured":"Wanders RJ, et al. Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid beta-oxidation. Biochem Biophys Res Commun. 1992;188(3):1139\u201345.","journal-title":"Biochem Biophys Res Commun"},{"issue":"22","key":"9448_CR20","doi-asserted-by":"publisher","first-page":"2248","DOI":"10.1161\/01.CIR.100.22.2248","volume":"100","author":"D Bonnet","year":"1999","unstructured":"Bonnet D, et al. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation. 1999;100(22):2248\u201353.","journal-title":"Circulation"},{"issue":"4","key":"9448_CR21","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1007\/s10545-009-1125-9","volume":"32","author":"U Spiekerkoetter","year":"2009","unstructured":"Spiekerkoetter U, et al. Management and outcome in 75 individuals with long-chain fatty acid oxidation defects: results from a workshop. J Inherit Metab Dis. 2009;32(4):488\u201397.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"9448_CR22","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s10545-010-9090-x","volume":"33","author":"U Spiekerkoetter","year":"2010","unstructured":"Spiekerkoetter U. Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening. J Inherit Metab Dis. 2010;33(5):527\u201332.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"9448_CR23","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s10545-012-9542-6","volume":"36","author":"J Baruteau","year":"2013","unstructured":"Baruteau J, et al. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study of 187 patients. J Inherit Metab Dis. 2013;36(5):795\u2013803.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"9448_CR24","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s10545-013-9628-9","volume":"37","author":"J Baruteau","year":"2014","unstructured":"Baruteau J, et al. Clinical and biological features at diagnosis in mitochondrial fatty acid beta-oxidation defects: a French pediatric study from 187 patients. Complementary data. J Inherit Metab Dis. 2014;37(1):137\u20139.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"9448_CR25","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1023\/A:1005556207210","volume":"22","author":"JM Saudubray","year":"1999","unstructured":"Saudubray JM, et al. Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis. 1999;22(4):488\u2013502.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"9448_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0009-8981(97)00185-X","volume":"269","author":"C Vianey-Saban","year":"1998","unstructured":"Vianey-Saban C, et al. Mitochondrial very-long-chain acyl-coenzyme a dehydrogenase deficiency: clinical characteristics and diagnostic considerations in 30 patients. Clin Chim Acta. 1998;269(1):43\u201362.","journal-title":"Clin Chim Acta"},{"issue":"4","key":"9448_CR27","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s004310050063","volume":"159","author":"AM Das","year":"2000","unstructured":"Das AM, et al. Secondary respiratory chain defect in a boy with long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: possible diagnostic pitfalls. Eur J Pediatr. 2000;159(4):243\u20136.","journal-title":"Eur J Pediatr"},{"issue":"5","key":"9448_CR28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1203\/00006450-198305000-00003","volume":"17","author":"AM Glasgow","year":"1983","unstructured":"Glasgow AM, et al. Hypoglycemia, hepatic dysfunction, muscle weakness, cardiomyopathy, free carnitine deficiency and long-chain acylcarnitine excess responsive to medium chain triglyceride diet. Pediatr Res. 1983;17(5):319\u201326.","journal-title":"Pediatr Res"},{"issue":"2","key":"9448_CR29","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1016\/S0022-3476(98)70228-8","volume":"133","author":"GF Cox","year":"1998","unstructured":"Cox GF, et al. Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very-long-chain acyl-coenzyme a dehydrogenase deficiency. J Pediatr. 1998;133(2):247\u201353.","journal-title":"J Pediatr"},{"issue":"5","key":"9448_CR30","doi-asserted-by":"publisher","first-page":"354","DOI":"10.5001\/omj.2013.101","volume":"28","author":"SW Sharef","year":"2013","unstructured":"Sharef SW, Al-Senaidi K, Joshi SN. Successful treatment of cardiomyopathy due to very long-chain acyl-CoA dehydrogenase deficiency: first case report from Oman with literature review. Oman Med J. 2013;28(5):354\u20136.","journal-title":"Oman Med J"},{"issue":"4","key":"9448_CR31","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1097\/01.CCM.0000045201.10682.F6","volume":"31","author":"Stefan Kluge","year":"2003","unstructured":"Kluge S, K\u00fchnelt P, Block A, Merkel M, Gocht A, Lukacs Z, et al. A young woman with persistent hypoglycemia, rhabdomyolysis, and coma: recognizing fatty acid oxidation defects in adults. Crit Care Med. 2003;31(4):1273\u20136.","journal-title":"Critical Care Medicine"},{"issue":"2","key":"9448_CR32","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1136\/jnnp.62.2.169","volume":"62","author":"J Schaefer","year":"1997","unstructured":"Schaefer J, et al. Characterisation of carnitine palmitoyltransferases in patients with a carnitine palmitoyltransferase deficiency: implications for diagnosis and therapy. J Neurol Neurosurg Psychiatry. 1997;62(2):169\u201376.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"9","key":"9448_CR33","doi-asserted-by":"publisher","first-page":"728","DOI":"10.1016\/j.bbadis.2010.06.002","volume":"1802","author":"S Violante","year":"2010","unstructured":"Violante S, et al. Carnitine palmitoyltransferase 2: new insights on the substrate specificity and implications for acylcarnitine profiling. Biochim Biophys Acta (BBA) - Mol Basis Dis. 2010;1802(9):728\u201332.","journal-title":"Biochim Biophys Acta (BBA) - Mol Basis Dis"},{"issue":"2","key":"9448_CR34","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0003-2697(89)90441-7","volume":"180","author":"DS Millington","year":"1989","unstructured":"Millington DS, et al. Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography\/mass spectrometry to the analysis of acylcarnitines in human urine, blood, and tissue. Anal Biochem. 1989;180(2):331\u20139.","journal-title":"Anal Biochem"},{"issue":"3","key":"9448_CR35","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1203\/00006450-199509000-00009","volume":"38","author":"MS Rashed","year":"1995","unstructured":"Rashed MS, et al. Diagnosis of inborn errors of metabolism from blood spots by acylcarnitines and amino acids profiling using automated electrospray tandem mass spectrometry. Pediatr Res. 1995;38(3):324\u201331.","journal-title":"Pediatr Res"},{"issue":"4","key":"9448_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.4103\/0972-2327.144031","volume":"17","author":"Y Topcu","year":"2014","unstructured":"Topcu Y, et al. Importance of acylcarnitine profile analysis for disorders of lipid metabolism in adolescent patients with recurrent rhabdomyolysis: report of two cases. Ann Indian Acad Neurol. 2014;17(4):437\u201340.","journal-title":"Ann Indian Acad Neurol"},{"key":"9448_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/8904_2011_35","volume":"3","author":"L Borch","year":"2012","unstructured":"Borch L, et al. Normal levels of plasma free carnitine and Acylcarnitines in follow-up samples from a Presymptomatic case of carnitine Palmitoyl transferase 1 (CPT1) deficiency detected through newborn screening in Denmark. JIMD Rep. 2012;3:11\u20135.","journal-title":"JIMD Rep"},{"issue":"4","key":"9448_CR38","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1007\/s10545-005-0545-4","volume":"28","author":"MF Browning","year":"2005","unstructured":"Browning MF, et al. Normal acylcarnitine levels during confirmation of abnormal newborn screening in long-chain fatty acid oxidation defects. J Inherit Metab Dis. 2005;28(4):545\u201350.","journal-title":"J Inherit Metab Dis"},{"key":"9448_CR39","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jpeds.2015.10.045","volume":"169","author":"LC Burrage","year":"2016","unstructured":"Burrage LC, et al. Elevations of C14:1 and C14:2 plasma Acylcarnitines in fasted children: a diagnostic dilemma. J Pediatr. 2016;169:208\u2013213.e2.","journal-title":"J Pediatr"},{"key":"9448_CR40","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/8904_2012_129","volume":"6","author":"U Spiekerkoetter","year":"2012","unstructured":"Spiekerkoetter U, et al. Lethal undiagnosed very long-chain acyl-CoA dehydrogenase deficiency with mild C14-Acylcarnitine abnormalities on newborn screening. JIMD Rep. 2012;6:113\u20135.","journal-title":"JIMD Rep"},{"issue":"1\u20132","key":"9448_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0009-8981(98)00188-0","volume":"281","author":"FV Ventura","year":"1999","unstructured":"Ventura FV, et al. Quantitative acylcarnitine profiling in fibroblasts using [U-13C] palmitic acid: an improved tool for the diagnosis of fatty acid oxidation defects. Clin Chim Acta. 1999;281(1\u20132):1\u201317.","journal-title":"Clin Chim Acta"},{"issue":"10","key":"9448_CR42","doi-asserted-by":"publisher","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","volume":"1863","author":"N Longo","year":"2016","unstructured":"Longo N, Frigeni M, Pasquali M. Carnitine transport and fatty acid oxidation. Biochim Biophys Acta. 2016;1863(10):2422\u201335.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"9448_CR43","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1097\/GIM.0b013e31820d5e67","volume":"13","author":"D McHugh","year":"2011","unstructured":"McHugh D, et al. Clinical validation of cutoff target ranges in newborn screening of metabolic disorders by tandem mass spectrometry: a worldwide collaborative project. Genet Med. 2011;13(3):230\u201354.","journal-title":"Genet Med"},{"issue":"10","key":"9448_CR44","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/clinchem\/47.10.1763","volume":"47","author":"R Fingerhut","year":"2001","unstructured":"Fingerhut R, et al. Hepatic carnitine palmitoyltransferase I deficiency: acylcarnitine profiles in blood spots are highly specific. Clin Chem. 2001;47(10):1763\u20138.","journal-title":"Clin Chem"},{"issue":"1","key":"9448_CR45","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1023\/A:1015109127986","volume":"25","author":"K Gempel","year":"2002","unstructured":"Gempel K, et al. Screening for carnitine Palmitoyltransferase II deficiency by tandem mass spectrometry. J Inherit Metab Dis. 2002;25(1):17\u201327.","journal-title":"J Inherit Metab Dis"},{"key":"9448_CR46","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/8904_2015_476","volume":"27","author":"E Diekman","year":"2016","unstructured":"Diekman E, et al. The newborn screening paradox: sensitivity vs. Overdiagnosis in VLCAD deficiency. JIMD Rep. 2016;27:101\u20136.","journal-title":"JIMD Rep"},{"issue":"2","key":"9448_CR47","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.ymgme.2005.02.002","volume":"85","author":"J Sander","year":"2005","unstructured":"Sander J, et al. Neonatal screening for defects of the mitochondrial trifunctional protein. Mol Genet Metab. 2005;85(2):108\u201314.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"9448_CR48","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/BF01799333","volume":"13","author":"NJ Manning","year":"1990","unstructured":"Manning NJ, et al. A comparison of [9,10-3H]palmitic and [9,10-3H]myristic acids for the detection of defects of fatty acid oxidation in intact cultured fibroblasts. J Inherit Metab Dis. 1990;13(1):58\u201368.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"9448_CR49","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1023\/A:1005358802096","volume":"20","author":"SE Olpin","year":"1997","unstructured":"Olpin SE, et al. Improved detection of long-chain fatty acid oxidation defects in intact cells using [9,10-3H]oleic acid. J Inherit Metab Dis. 1997;20(3):415\u20139.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"9448_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1002\/humu.1174","volume":"18","author":"N Gregersen","year":"2001","unstructured":"Gregersen N, et al. Mutation analysis in mitochondrial fatty acid oxidation defects: exemplified by acyl-CoA dehydrogenase deficiencies, with special focus on genotype-phenotype relationship. Hum Mutat. 2001;18(3):169\u201389.","journal-title":"Hum Mutat"},{"issue":"3","key":"9448_CR51","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.ymgme.2015.08.011","volume":"116","author":"MJ Miller","year":"2015","unstructured":"Miller MJ, et al. Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States. Mol Genet Metab. 2015;116(3):139\u201345.","journal-title":"Mol Genet Metab"},{"key":"9448_CR52","doi-asserted-by":"publisher","unstructured":"Bleeker JC, Kok IL, Ferdinandusse S, et al. Proposal for an individualized dietary strategy in patients with very long-chain acyl-CoA dehydrogenase deficiency. J Inherit Metab Dis 2018. https:\/\/doi.org\/10.1007\/s10545-018-0164-5 .","DOI":"10.1007\/s10545-018-0164-5"},{"key":"9448_CR53","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ymgme.2016.05.007","volume":"118","author":"LD Pena","year":"2016","unstructured":"Pena LD, et al. Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database. Mol Genet Metab. 2016;118:272\u201381.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"9448_CR54","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10545-012-9483-0","volume":"35","author":"JG Loeber","year":"2012","unstructured":"Loeber JG, et al. Newborn screening programmes in Europe; arguments and efforts regarding harmonization. Part 1. From blood spot to screening result. J Inherit Metab Dis. 2012;35(4):603\u201311.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"9448_CR55","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1007\/s10545-010-9076-8","volume":"33","author":"M Lindner","year":"2010","unstructured":"Lindner M, Hoffmann GF, Matern D. Newborn screening for disorders of fatty-acid oxidation: experience and recommendations from an expert meeting. J Inherit Metab Dis. 2010;33(5):521\u20136.","journal-title":"J Inherit Metab Dis"},{"issue":"1\u20132","key":"9448_CR56","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.ymgme.2013.04.008","volume":"110","author":"MG Sain-van der Velden de","year":"2013","unstructured":"de Sain-van der Velden MG, et al. Differences between acylcarnitine profiles in plasma and bloodspots. Mol Genet Metab. 2013;110(1\u20132):116\u201321.","journal-title":"Mol Genet Metab"},{"issue":"12","key":"9448_CR57","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/gim.2014.62","volume":"16","author":"PL Hall","year":"2014","unstructured":"Hall PL, et al. Postanalytical tools improve performance of newborn screening by tandem mass spectrometry. Genet Med. 2014;16(12):889\u201395.","journal-title":"Genet Med"},{"key":"9448_CR58","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1750-1172-6-44","volume":"6","author":"M Lindner","year":"2011","unstructured":"Lindner M, et al. Efficacy and outcome of expanded newborn screening for metabolic diseases--report of 10 years from south-West Germany. Orphanet J Rare Dis. 2011;6:44.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"9448_CR59","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.ymgme.2014.01.009","volume":"111","author":"JL Merritt Ii","year":"2014","unstructured":"Merritt Ii JL, et al. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening. Mol Genet Metab. 2014;111(4):484\u201392.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"9448_CR60","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.ymgme.2016.05.012","volume":"118","author":"M Evans","year":"2016","unstructured":"Evans M, et al. VLCAD deficiency: follow-up and outcome of patients diagnosed through newborn screening in Victoria. Mol Genet Metab. 2016;118(4):282\u20137.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"9448_CR61","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s10545-015-9911-z","volume":"39","author":"B Ryder","year":"2016","unstructured":"Ryder B, et al. The natural history of elevated tetradecenoyl-L-carnitine detected by newborn screening in New Zealand: implications for very long chain acyl-CoA dehydrogenase deficiency screening and treatment. J Inherit Metab Dis. 2016;39(3):409\u201314.","journal-title":"J Inherit Metab Dis"},{"key":"9448_CR62","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13023-015-0236-7","volume":"10","author":"D Karall","year":"2015","unstructured":"Karall D, et al. Clinical outcome, biochemical and therapeutic follow-up in 14 Austrian patients with long-chain 3-Hydroxy acyl CoA dehydrogenase deficiency (LCHADD). Orphanet J Rare Dis. 2015;10:21.","journal-title":"Orphanet J Rare Dis"},{"key":"9448_CR63","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/8904_2016_558","volume":"31","author":"I Biase De","year":"2017","unstructured":"De Biase I, et al. Diagnosis, treatment, and clinical outcome of patients with mitochondrial trifunctional protein\/long-chain 3-Hydroxy acyl-CoA dehydrogenase deficiency. JIMD Rep. 2017;31:63\u201371.","journal-title":"JIMD Rep"},{"issue":"2","key":"9448_CR64","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/ajmg.c.30087","volume":"142c","author":"N Longo","year":"2006","unstructured":"Longo N, Amat di San Filippo C, Pasquali M. Disorders of carnitine transport and the carnitine cycle. Am J Med Genet C Semin Med Genet. 2006;142c(2):77\u201385.","journal-title":"Am J Med Genet C Semin Med Genet"},{"issue":"6","key":"9448_CR65","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1023\/B:BOLI.0000045837.23328.f4","volume":"27","author":"N Makhseed","year":"2004","unstructured":"Makhseed N, et al. Carnitine transporter defect due to a novel mutation in the SLC22A5 gene presenting with peripheral neuropathy. J Inherit Metab Dis. 2004;27(6):778\u201380.","journal-title":"J Inherit Metab Dis"},{"issue":"4","key":"9448_CR66","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1159\/000107675","volume":"51","author":"Muferet Erguven","year":"2007","unstructured":"Erguven M, Y\u0131lmaz O, Koc S, Cak\u0131 S, Ayhan Y, Donmez M, et al. A case of early diagnosed carnitine deficiency presenting with respiratory symptoms. Ann Nutr Metab. 2007;51(4):331\u20134.","journal-title":"Annals of Nutrition and Metabolism"},{"issue":"6","key":"9448_CR67","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1097\/00125817-200111000-00002","volume":"3","author":"Y Wang","year":"2001","unstructured":"Wang Y, et al. Phenotype and genotype variation in primary carnitine deficiency. Genet Med. 2001;3(6):387\u201392.","journal-title":"Genet Med"},{"issue":"2","key":"9448_CR68","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1007\/s10545-013-9606-2","volume":"37","author":"J Rasmussen","year":"2014","unstructured":"Rasmussen J, et al. Carnitine levels in 26,462 individuals from the nationwide screening program for primary carnitine deficiency in the Faroe Islands. J Inherit Metab Dis. 2014;37(2):215\u201322.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"9448_CR69","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s10545-012-9488-8","volume":"36","author":"J Rasmussen","year":"2013","unstructured":"Rasmussen J, Nielsen OW, Lund AM, K\u00f8ber L, Djurhuus H. Primary carnitine deficiency and pivalic acid exposure causing encephalopathy and fatal cardiac events. J Inherit Metab Dis. 2013;36(1):35\u201341.","journal-title":"J Inherit Metab Dis"},{"issue":"12","key":"9448_CR70","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1093\/hmg\/8.12.2247","volume":"8","author":"A Koizumi","year":"1999","unstructured":"Koizumi A, et al. Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency. Hum Mol Genet. 1999;8(12):2247\u201354.","journal-title":"Hum Mol Genet"},{"issue":"4","key":"9448_CR71","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1067\/mpd.2001.111813","volume":"138","author":"B Wilcken","year":"2001","unstructured":"Wilcken B, et al. Carnitine transporter defect diagnosed by newborn screening with electrospray tandem mass spectrometry. J Pediatr. 2001;138(4):581\u20134.","journal-title":"J Pediatr"},{"issue":"Suppl 3","key":"9448_CR72","doi-asserted-by":"publisher","first-page":"S133","DOI":"10.1007\/s10545-010-9048-z","volume":"33","author":"L Vilarinho","year":"2010","unstructured":"Vilarinho L, et al. Four years of expanded newborn screening in Portugal with tandem mass spectrometry. J Inherit Metab Dis. 2010;33(Suppl 3):S133\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"1\u20132","key":"9448_CR73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ymgme.2014.07.009","volume":"113","author":"BL Therrell Jr","year":"2014","unstructured":"Therrell BL Jr, Lloyd-Puryear MA, Camp KM, Mann MY. Inborn errors of metabolism identified via newborn screening: ten-year incidence data and costs of nutritional interventions for research agenda planning. Mol Genet Metab. 2014;113(1\u20132):14\u201326.","journal-title":"Mol Genet Metab"},{"issue":"6 Pt 1","key":"9448_CR74","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1542\/peds.111.6.1399","volume":"111","author":"A Schulze","year":"2003","unstructured":"Schulze A, et al. Expanded newborn screening for inborn errors of metabolism by electrospray ionization-tandem mass spectrometry: results, outcome, and implications. Pediatrics. 2003;111(6 Pt 1):1399\u2013406.","journal-title":"Pediatrics"},{"issue":"1","key":"9448_CR75","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1097\/GIM.0b013e3181c5e6f7","volume":"12","author":"AW El-Hattab","year":"2010","unstructured":"El-Hattab AW, et al. Maternal systemic primary carnitine deficiency uncovered by newborn screening: clinical, biochemical, and molecular aspects. Genet Med. 2010;12(1):19\u201324.","journal-title":"Genet Med"},{"issue":"1","key":"9448_CR76","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/humu.21607","volume":"33","author":"EC Rose","year":"2012","unstructured":"Rose EC, et al. Genotype-phenotype correlation in primary carnitine deficiency. Hum Mutat. 2012;33(1):118\u201323.","journal-title":"Hum Mutat"},{"issue":"5","key":"9448_CR77","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/S0022-3476(81)80834-7","volume":"98","author":"PF Bougneres","year":"1981","unstructured":"Bougneres PF, et al. Fasting hypoglycemia resulting from hepatic carnitine palmitoyl transferase deficiency. J Pediatr. 1981;98(5):742\u20136.","journal-title":"J Pediatr"},{"issue":"3","key":"9448_CR78","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1203\/00006450-198809000-00006","volume":"24","author":"F Demaugre","year":"1988","unstructured":"Demaugre F, et al. Hepatic and muscular presentations of carnitine palmitoyl transferase deficiency: two distinct entities. Pediatr Res. 1988;24(3):308\u201311.","journal-title":"Pediatr Res"},{"issue":"4","key":"9448_CR79","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1007\/BF01956748","volume":"152","author":"C Vianey-Saban","year":"1993","unstructured":"Vianey-Saban C, et al. Carnitine palmitoyl transferase I deficiency presenting as a Reye-like syndrome without hypoglycaemia. Eur J Pediatr. 1993;152(4):334\u20138.","journal-title":"Eur J Pediatr"},{"issue":"1","key":"9448_CR80","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1056\/NEJM199207023270105","volume":"327","author":"ZC Falik-Borenstein","year":"1992","unstructured":"Falik-Borenstein ZC, et al. Brief report: renal tubular acidosis in carnitine palmitoyltransferase type 1 deficiency. N Engl J Med. 1992;327(1):24\u20137.","journal-title":"N Engl J Med"},{"issue":"5","key":"9448_CR81","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1203\/00006450-199411000-00007","volume":"36","author":"AJ Bergman","year":"1994","unstructured":"Bergman AJ, et al. Rate-dependent distal renal tubular acidosis and carnitine palmitoyltransferase I deficiency. Pediatr Res. 1994;36(5):582\u20138.","journal-title":"Pediatr Res"},{"issue":"3","key":"9448_CR82","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.ymgme.2005.07.022","volume":"86","author":"SH Korman","year":"2005","unstructured":"Korman SH, et al. Novel metabolic and molecular findings in hepatic carnitine palmitoyltransferase I deficiency. Mol Genet Metab. 2005;86(3):337\u201343.","journal-title":"Mol Genet Metab"},{"issue":"1","key":"9448_CR83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1203\/00006450-200001000-00010","volume":"47","author":"AM Innes","year":"2000","unstructured":"Innes AM, et al. Hepatic carnitine palmitoyltransferase I deficiency presenting as maternal illness in pregnancy. Pediatr Res. 2000;47(1):43\u20135.","journal-title":"Pediatr Res"},{"issue":"3","key":"9448_CR84","doi-asserted-by":"publisher","first-page":"e001618","DOI":"10.1161\/CIRCGENETICS.116.001618","volume":"10","author":"L Skotte","year":"2017","unstructured":"Skotte L, et al. CPT1A missense mutation associated with fatty acid metabolism and reduced height in Greenlanders. Circ Cardiovasc Genet. 2017;10(3):e001618.","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"9448_CR85","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1006\/mgme.2001.3149","volume":"73","author":"C Prasad","year":"2001","unstructured":"Prasad C, et al. Hepatic carnitine palmitoyl transferase 1 (CPT1 a) deficiency in north American Hutterites (Canadian and American): evidence for a founder effect and results of a pilot study on a DNA-based newborn screening program. Mol Genet Metab. 2001;73(1):55\u201363.","journal-title":"Mol Genet Metab"},{"issue":"8","key":"9448_CR86","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/gim.2016.202","volume":"19","author":"AE Fohner","year":"2017","unstructured":"Fohner AE, et al. Carnitine palmitoyltransferase 1A P479L and infant death: policy implications of emerging data. Genet Med. 2017;19(8):851\u20137.","journal-title":"Genet Med"},{"key":"9448_CR87","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/1471-2431-12-190","volume":"12","author":"SA Collins","year":"2012","unstructured":"Collins SA, et al. Causes and risk factors for infant mortality in Nunavut, Canada 1999-2011. BMC Pediatr. 2012;12:190.","journal-title":"BMC Pediatr"},{"issue":"5","key":"9448_CR88","doi-asserted-by":"publisher","first-page":"e1162","DOI":"10.1542\/peds.2011-2924","volume":"130","author":"GB Sinclair","year":"2012","unstructured":"Sinclair GB, et al. Carnitine palmitoyltransferase I and sudden unexpected infant death in British Columbia first nations. Pediatrics. 2012;130(5):e1162\u20139.","journal-title":"Pediatrics"},{"issue":"9","key":"9448_CR89","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/gim.2015.197","volume":"18","author":"BD Gessner","year":"2016","unstructured":"Gessner BD, et al. Evidence for an association between infant mortality and homozygosity for the arctic variant of carnitine palmitoyltransferase 1A. Genet Med. 2016;18(9):933\u20139.","journal-title":"Genet Med"},{"issue":"5","key":"9448_CR90","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1542\/peds.2010-0687","volume":"126","author":"BD Gessner","year":"2010","unstructured":"Gessner BD, et al. Evidence for an association between infant mortality and a carnitine palmitoyltransferase 1A genetic variant. Pediatrics. 2010;126(5):945\u201351.","journal-title":"Pediatrics"},{"issue":"13","key":"9448_CR91","doi-asserted-by":"publisher","first-page":"11473","DOI":"10.1074\/jbc.M111628200","volume":"277","author":"M Morillas","year":"2002","unstructured":"Morillas M, et al. Structural model of a malonyl-CoA-binding site of carnitine octanoyltransferase and carnitine palmitoyltransferase I: mutational analysis of a malonyl-CoA affinity domain. J Biol Chem. 2002;277(13):11473\u201380.","journal-title":"J Biol Chem"},{"issue":"7","key":"9448_CR92","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/S0022-2275(20)31604-7","volume":"42","author":"NF Brown","year":"2001","unstructured":"Brown NF, et al. Molecular characterization of L-CPT I deficiency in six patients: insights into function of the native enzyme. J Lipid Res. 2001;42(7):1134\u201342.","journal-title":"J Lipid Res"},{"issue":"11","key":"9448_CR93","doi-asserted-by":"publisher","first-page":"9058","DOI":"10.1074\/jbc.M209999200","volume":"278","author":"M Morillas","year":"2003","unstructured":"Morillas M, et al. Identification of conserved amino acid residues in rat liver carnitine palmitoyltransferase I critical for malonyl-CoA inhibition. Mutation of methionine 593 abolishes malonyl-CoA inhibition. J Biol Chem. 2003;278(11):9058\u201363.","journal-title":"J Biol Chem"},{"key":"9448_CR94","unstructured":"Butler JC, McLaughlin J. Carnitine palmitoyl transferase-1A deficiency rates in alaska. State of alaska bulletin 2006;19. Retrieved from http:\/\/www.epi.Alaska.gov . Accessed on 12 January 2018."},{"key":"9448_CR95","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/8904_2013_236","volume":"11","author":"YH Chien","year":"2013","unstructured":"Chien YH, et al. Fatty acid oxidation disorders in a chinese population in Taiwan. JIMD Rep. 2013;11:165\u201372.","journal-title":"JIMD Rep"},{"issue":"1","key":"9448_CR96","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1023\/A:1005606805951","volume":"24","author":"KG Sim","year":"2001","unstructured":"Sim KG, et al. Carnitine palmitoyltransferase I deficiency in neonate identified by dried blood spot free carnitine and acylcarnitine profile. J Inherit Metab Dis. 2001;24(1):51\u20139.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"9448_CR97","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/BF01800021","volume":"15","author":"CA Stanley","year":"1992","unstructured":"Stanley CA, et al. Elevated plasma carnitine in the hepatic form of carnitine palmitoyltransferase-1 deficiency. J Inherit Metab Dis. 1992;15(5):785\u20139.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"9448_CR98","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ymgme.2006.07.006","volume":"90","author":"N Vlies van","year":"2007","unstructured":"van Vlies N, et al. An improved enzyme assay for carnitine palmitoyl transferase I in fibroblasts using tandem mass spectrometry. Mol Genet Metab. 2007;90(1):24\u20139.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"9448_CR99","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1172\/JCI2927","volume":"102","author":"L IJlst","year":"1998","unstructured":"IJlst L, et al. Molecular basis of hepatic carnitine palmitoyltransferase I deficiency. J Clin Invest. 1998;102(3):527\u201331.","journal-title":"J Clin Invest"},{"issue":"50","key":"9448_CR100","doi-asserted-by":"publisher","first-page":"50428","DOI":"10.1074\/jbc.M310130200","volume":"278","author":"S Gobin","year":"2003","unstructured":"Gobin S, et al. Functional and structural basis of carnitine palmitoyltransferase 1A deficiency. J Biol Chem. 2003;278(50):50428\u201334.","journal-title":"J Biol Chem"},{"issue":"1","key":"9448_CR101","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.jpeds.2010.07.031","volume":"158","author":"BD Gessner","year":"2011","unstructured":"Gessner BD, et al. Prevalence and distribution of the c.1436C-->T sequence variant of carnitine palmitoyltransferase 1A among Alaska Native infants. J Pediatr. 2011;158(1):124\u20139.","journal-title":"J Pediatr"},{"key":"9448_CR102","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/8904_2014_382","volume":"20","author":"I Vitoria","year":"2015","unstructured":"Vitoria I, et al. Carnitine-acylcarnitine translocase deficiency: experience with four cases in Spain and review of the literature. JIMD Rep. 2015;20:11\u201320.","journal-title":"JIMD Rep"},{"issue":"4","key":"9448_CR103","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1111\/j.1651-2227.2003.tb00586.x","volume":"92","author":"ME Rubio-Gozalbo","year":"2003","unstructured":"Rubio-Gozalbo ME, et al. Carnitine-acylcarnitine translocase deficiency: case report and review of the literature. Acta Paediatr. 2003;92(4):501\u20134.","journal-title":"Acta Paediatr"},{"issue":"4","key":"9448_CR104","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.ymgme.2011.05.001","volume":"103","author":"GL Wang","year":"2011","unstructured":"Wang GL, et al. Expanded molecular features of carnitine acyl-carnitine translocase (CACT) deficiency by comprehensive molecular analysis. Mol Genet Metab. 2011;103(4):349\u201357.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"9448_CR105","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1006\/bbrc.2000.4178","volume":"280","author":"L IJlst","year":"2001","unstructured":"IJlst L, et al. Functional analysis of mutant human carnitine acylcarnitine translocases in yeast. Biochem Biophys Res Commun. 2001;280(3):700\u20136.","journal-title":"Biochem Biophys Res Commun"},{"issue":"5\u20136","key":"9448_CR106","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/j.mam.2004.06.004","volume":"25","author":"JP Bonnefont","year":"2004","unstructured":"Bonnefont JP, et al. Carnitine palmitoyltransferases 1 and 2: biochemical, molecular and medical aspects. Mol Asp Med. 2004;25(5\u20136):495\u2013520.","journal-title":"Mol Asp Med"},{"issue":"6","key":"9448_CR107","doi-asserted-by":"publisher","DOI":"10.1542\/peds.107.6.e103","volume":"107","author":"S Albers","year":"2001","unstructured":"Albers S, et al. Detection of neonatal carnitine palmitoyltransferase II deficiency by expanded newborn screening with tandem mass spectrometry. Pediatrics. 2001;107(6):E103.","journal-title":"Pediatrics"},{"issue":"3","key":"9448_CR108","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/S0022-3476(95)70073-0","volume":"127","author":"KN North","year":"1995","unstructured":"North KN, et al. Lethal neonatal deficiency of carnitine palmitoyltransferase II associated with dysgenesis of the brain and kidneys. J Pediatr. 1995;127(3):414\u201320.","journal-title":"J Pediatr"},{"issue":"4","key":"9448_CR109","first-page":"A73","volume":"29","author":"AB Zinn","year":"1991","unstructured":"Zinn AB, et al. Carnitine Palmitoyltransferase-B (Cpt B) deficiency - a heritable cause of neonatal cardiomyopathy and dysgenesis of the kidney. Pediatr Res. 1991;29(4):A73.","journal-title":"Pediatr Res"},{"key":"9448_CR110","unstructured":"Witt DR, et al. Carnitine Palmitoyl transferase-type 2 deficiency - 2 new cases and successful prenatal-diagnosis. Am J Hum Genet. 1991;49(4):109\u20139."},{"key":"9448_CR111","first-page":"95","volume":"89","author":"KR Norum","year":"1964","unstructured":"Norum KR. Palmityl-Coa:carnitine palmityltransferase. purification from calf-liver mitochondria and some properties of the enzyme. Biochim Biophys Acta. 1964;89:95\u2013108.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"9448_CR112","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1111\/j.1432-1033.1985.tb08913.x","volume":"149","author":"S Zierz","year":"1985","unstructured":"Zierz S, Engel AG. Regulatory properties of a mutant carnitine palmitoyltransferase in human skeletal muscle. Eur J Biochem. 1985;149(1):207\u201314.","journal-title":"Eur J Biochem"},{"issue":"6","key":"9448_CR113","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1023\/A:1025947930752","volume":"26","author":"SE Olpin","year":"2003","unstructured":"Olpin SE, et al. Mutation and biochemical analysis in carnitine palmitoyltransferase type II (CPT II) deficiency. J Inherit Metab Dis. 2003;26(6):543\u201357.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"9448_CR114","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1002\/humu.10201","volume":"21","author":"L Thuillier","year":"2003","unstructured":"Thuillier L, et al. Correlation between genotype, metabolic data, and clinical presentation in carnitine palmitoyltransferase 2 (CPT2) deficiency. Hum Mutat. 2003;21(5):493\u2013501.","journal-title":"Hum Mutat"},{"issue":"4","key":"9448_CR115","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1006\/mgme.1999.2938","volume":"68","author":"JP Bonnefont","year":"1999","unstructured":"Bonnefont JP, et al. Carnitine palmitoyltransferase deficiencies. Mol Genet Metab. 1999;68(4):424\u201340.","journal-title":"Mol Genet Metab"},{"issue":"1\u20132","key":"9448_CR116","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.jns.2013.12.026","volume":"338","author":"PR Joshi","year":"2014","unstructured":"Joshi PR, Deschauer M, Zierz S. Carnitine palmitoyltransferase II (CPT II) deficiency: genotype-phenotype analysis of 50 patients. J Neurol Sci. 2014;338(1\u20132):107\u201311.","journal-title":"J Neurol Sci"},{"issue":"4","key":"9448_CR117","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.ymgme.2006.08.004","volume":"89","author":"PJ Isackson","year":"2006","unstructured":"Isackson PJ, Bennett MJ, Vladutiu GD. Identification of 16 new disease-causing mutations in the CPT2 gene resulting in carnitine palmitoyltransferase II deficiency. Mol Genet Metab. 2006;89(4):323\u201331.","journal-title":"Mol Genet Metab"},{"issue":"3","key":"9448_CR118","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jpeds.2009.10.031","volume":"156","author":"C Ficicioglu","year":"2010","unstructured":"Ficicioglu C, et al. Very long-chain acyl-CoA dehydrogenase deficiency in a patient with normal newborn screening by tandem mass spectrometry. J Pediatr. 2010;156(3):492\u20134.","journal-title":"J Pediatr"},{"issue":"3","key":"9448_CR119","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1258\/jrsm.2011.110075","volume":"105","author":"JW Pryce","year":"2012","unstructured":"Pryce JW, et al. Changing patterns of infant death over the last 100 years: autopsy experience from a specialist children's hospital. J R Soc Med. 2012;105(3):123\u201330.","journal-title":"J R Soc Med"},{"issue":"2","key":"9448_CR120","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.ymgme.2005.12.012","volume":"88","author":"A Boneh","year":"2006","unstructured":"Boneh A, et al. VLCAD deficiency: pitfalls in newborn screening and confirmation of diagnosis by mutation analysis. Mol Genet Metab. 2006;88(2):166\u201370.","journal-title":"Mol Genet Metab"},{"issue":"4","key":"9448_CR121","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.ymgme.2016.05.007","volume":"118","author":"LD Pena","year":"2016","unstructured":"Pena LD, et al. Outcomes and genotype-phenotype correlations in 52 individuals with VLCAD deficiency diagnosed by NBS and enrolled in the IBEM-IS database. Mol Genet Metab. 2016;118(4):272\u201381.","journal-title":"Mol Genet Metab"},{"issue":"10","key":"9448_CR122","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1161\/01.CIR.99.10.1337","volume":"99","author":"A Mathur","year":"1999","unstructured":"Mathur A, et al. Molecular heterogeneity in very-long-chain acyl-CoA dehydrogenase deficiency causing pediatric cardiomyopathy and sudden death. Circulation. 1999;99(10):1337\u201343.","journal-title":"Circulation"},{"issue":"2","key":"9448_CR123","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1086\/302261","volume":"64","author":"BS Andresen","year":"1999","unstructured":"Andresen BS, et al. Clear correlation of genotype with disease phenotype in very-long-chain acyl-CoA dehydrogenase deficiency. Am J Hum Genet. 1999;64(2):479\u201394.","journal-title":"Am J Hum Genet"},{"issue":"12","key":"9448_CR124","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1038\/gim.2015.22","volume":"17","author":"EF Diekman","year":"2015","unstructured":"Diekman EF, et al. Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiency. Genet Med. 2015;17(12):989\u201394.","journal-title":"Genet Med"},{"issue":"3","key":"9448_CR125","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1373\/clinchem.2005.062000","volume":"52","author":"AM Das","year":"2006","unstructured":"Das AM, et al. Isolated Mitochondrial Long-Chain Ketoacyl-CoA Thiolase Deficiency Resulting from Mutations in the HADHB Gene. Clin Chem. 2006;52(3):530\u20134.","journal-title":"Clin Chem"},{"issue":"3","key":"9448_CR126","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1080\/15513819709168585","volume":"17","author":"T Tyni","year":"1997","unstructured":"Tyni T, et al. Pathology of long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation. Pediatr Pathol Lab Med. 1997;17(3):427\u201347.","journal-title":"Pediatr Pathol Lab Med"},{"issue":"6","key":"9448_CR127","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1067\/mpd.2003.231","volume":"142","author":"ME Boer den","year":"2003","unstructured":"den Boer ME, et al. Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement. J Pediatr. 2003;142(6):684\u20139.","journal-title":"J Pediatr"},{"issue":"1","key":"9448_CR128","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1542\/peds.109.1.99","volume":"109","author":"ME Boer den","year":"2002","unstructured":"den Boer ME, et al. Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: clinical presentation and follow-up of 50 patients. Pediatrics. 2002;109(1):99\u2013104.","journal-title":"Pediatrics"},{"issue":"6","key":"9448_CR129","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1080\/02713689808951227","volume":"17","author":"T Tyni","year":"1998","unstructured":"Tyni T, Pihko H, Kivela T. Ophthalmic pathology in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency caused by the G1528C mutation. Curr Eye Res. 1998;17(6):551\u20139.","journal-title":"Curr Eye Res"},{"issue":"10","key":"9448_CR130","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1016\/j.ophtha.2016.06.048","volume":"123","author":"EA Boese","year":"2016","unstructured":"Boese EA, et al. Characterization of Chorioretinopathy associated with mitochondrial trifunctional protein disorders: long-term follow-up of 21 cases. Ophthalmology. 2016;123(10):2183\u201395.","journal-title":"Ophthalmology"},{"key":"9448_CR131","first-page":"1","volume":"7","author":"EF Diekman","year":"2013","unstructured":"Diekman EF, et al. Necrotizing enterocolitis and respiratory distress syndrome as first clinical presentation of mitochondrial trifunctional protein deficiency. JIMD Rep. 2013;7:1\u20136.","journal-title":"JIMD Rep"},{"issue":"1","key":"9448_CR132","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0022-3476(96)70206-8","volume":"129","author":"C Dionisi-Vici","year":"1996","unstructured":"Dionisi-Vici C, et al. Hypoparathyroidism in mitochondrial trifunctional protein deficiency. J Pediatr. 1996;129(1):159\u201362.","journal-title":"J Pediatr"},{"issue":"5","key":"9448_CR133","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0022-3476(97)70111-2","volume":"131","author":"T Tyni","year":"1997","unstructured":"Tyni T, et al. Hypoparathyroidism in a patient with long-chain 3-hydroxyacyl-coenzyme a dehydrogenase deficiency caused by the G1528C mutation. J Pediatr. 1997;131(5):766\u20138.","journal-title":"J Pediatr"},{"issue":"6","key":"9448_CR134","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s00431-005-0052-5","volume":"165","author":"F Labarthe","year":"2006","unstructured":"Labarthe F, Benoist JF, Brivet M, Vianey-Saban C, Despert F, Ogier de Baulny H. Partial hypoparathyroidism associated with mitochondrial trifunctional protein deficiency. Eur J Pediatr. 2006;165(6):389\u201391.","journal-title":"Eur J Pediatr"},{"issue":"8842","key":"9448_CR135","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/0140-6736(93)92993-4","volume":"341","author":"B Wilcken","year":"1993","unstructured":"Wilcken B, et al. Pregnancy and fetal long-chain 3-hydroxyacyl coenzyme a dehydrogenase deficiency. Lancet. 1993;341(8842):407\u20138.","journal-title":"Lancet"},{"issue":"3","key":"9448_CR136","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/S0002-9378(98)70446-6","volume":"178","author":"T Tyni","year":"1998","unstructured":"Tyni T, Ekholm E, Pihko H. Pregnancy complications are frequent in long-chain 3-hydroxyacyl-coenzyme a dehydrogenase deficiency. Am J Obstet Gynecol. 1998;178(3):603\u20138.","journal-title":"Am J Obstet Gynecol"},{"issue":"6","key":"9448_CR137","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1038\/ajg.2017.54","volume":"112","author":"J Liu","year":"2017","unstructured":"Liu J, Ghaziani TT, Wolf JL. Acute fatty liver disease of pregnancy: updates in pathogenesis, diagnosis, and management. Am J Gastroenterol. 2017;112(6):838\u201346.","journal-title":"Am J Gastroenterol"},{"issue":"46","key":"9448_CR138","doi-asserted-by":"publisher","first-page":"7397","DOI":"10.3748\/wjg.v12.i46.7397","volume":"12","author":"JA Ibdah","year":"2006","unstructured":"Ibdah JA. Acute fatty liver of pregnancy: an update on pathogenesis and clinical implications. World J Gastroenterol. 2006;12(46):7397\u2013404.","journal-title":"World J Gastroenterol"},{"issue":"2","key":"9448_CR139","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.placenta.2011.11.027","volume":"33","author":"JL Bartha","year":"2012","unstructured":"Bartha JL, et al. Decreased mitochondrial fatty acid oxidation in placentas from women with preeclampsia. Placenta. 2012;33(2):132\u20134.","journal-title":"Placenta"},{"issue":"6","key":"9448_CR140","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s10545-014-9729-0","volume":"37","author":"S Moorthie","year":"2014","unstructured":"Moorthie S, et al. Systematic review and meta-analysis to estimate the birth prevalence of five inherited metabolic diseases. J Inherit Metab Dis. 2014;37(6):889\u201398.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"9448_CR141","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1203\/01.PDR.0000103931.80055.06","volume":"55","author":"U Spiekerkoetter","year":"2004","unstructured":"Spiekerkoetter U, et al. General mitochondrial trifunctional protein (TFP) deficiency as a result of either alpha- or beta-subunit mutations exhibits similar phenotypes because mutations in either subunit alter TFP complex expression and subunit turnover. Pediatr Res. 2004;55(2):190\u20136.","journal-title":"Pediatr Res"},{"issue":"4","key":"9448_CR142","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1172\/JCI118863","volume":"98","author":"L IJlst","year":"1996","unstructured":"IJlst L, et al. Common missense mutation G1528C in long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency. Characterization and expression of the mutant protein, mutation analysis on genomic DNA and chromosomal localization of the mitochondrial trifunctional protein alpha subunit gene. J Clin Invest. 1996;98(4):1028\u201333.","journal-title":"J Clin Invest"},{"issue":"4","key":"9448_CR143","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1007\/s10545-009-1126-8","volume":"32","author":"U Spiekerkoetter","year":"2009","unstructured":"Spiekerkoetter U, et al. Treatment recommendations in long-chain fatty acid oxidation defects: consensus from a workshop. J Inherit Metab Dis. 2009;32(4):498\u2013505.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"9448_CR144","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1007\/s10545-010-9208-1","volume":"33","author":"U Spiekerkoetter","year":"2010","unstructured":"Spiekerkoetter U, Mayatepek E. Update on mitochondrial fatty acid oxidation disorders. J Inherit Metab Dis. 2010;33(5):467\u20138.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"9448_CR145","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ymgme.2008.09.008","volume":"96","author":"GL Arnold","year":"2009","unstructured":"Arnold GL, et al. A Delphi clinical practice protocol for the management of very long chain acyl-CoA dehydrogenase deficiency. Mol Genet Metab. 2009;96(3):85\u201390.","journal-title":"Mol Genet Metab"},{"issue":"5","key":"9448_CR146","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1093\/ajcn\/36.5.950","volume":"36","author":"AC Bach","year":"1982","unstructured":"Bach AC, Babayan VK. Medium-chain triglycerides: an update. Am J Clin Nutr. 1982;36(5):950\u201362.","journal-title":"Am J Clin Nutr"},{"issue":"2","key":"9448_CR147","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10545-011-9391-8","volume":"35","author":"L Hoffmann","year":"2012","unstructured":"Hoffmann L, et al. VLCAD enzyme activity determinations in newborns identified by screening: a valuable tool for risk assessment. J Inherit Metab Dis. 2012;35(2):269\u201377.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"9448_CR148","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1007\/s10545-010-9188-1","volume":"33","author":"U Spiekerkoetter","year":"2010","unstructured":"Spiekerkoetter U, et al. Current issues regarding treatment of mitochondrial fatty acid oxidation disorders. J Inherit Metab Dis. 2010;33(5):555\u201361.","journal-title":"J Inherit Metab Dis"},{"issue":"1","key":"9448_CR149","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.hrthm.2015.07.027","volume":"13","author":"J Roussel","year":"2016","unstructured":"Roussel J, et al. Carnitine deficiency induces a short QT syndrome. Heart Rhythm. 2016;13(1):165\u201374.","journal-title":"Heart Rhythm"},{"issue":"5","key":"9448_CR150","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/j.1540-8159.2004.00507.x","volume":"27","author":"RS Rijlaarsdam","year":"2004","unstructured":"Rijlaarsdam RS, et al. Ventricular fibrillation without overt cardiomyopathy as first presentation of organic cation transporter 2-deficiency in adolescence. Pacing Clin Electrophysiol. 2004;27(5):675\u20136.","journal-title":"Pacing Clin Electrophysiol"},{"key":"9448_CR151","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1203\/00006450-198412000-00021","volume":"18","author":"RA Chalmers","year":"1984","unstructured":"Chalmers RA, et al. Urinary excretion of l-carnitine and Acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine. Pediatr Res. 1984;18:1325\u20138.","journal-title":"Pediatr Res"},{"key":"9448_CR152","doi-asserted-by":"crossref","unstructured":"Nasser, M., et al., Carnitine supplementation for inborn errors of metabolism. Cochrane Database Syst Rev, 2012(2): p. Cd006659.","DOI":"10.1002\/14651858.CD006659.pub3"},{"issue":"2A","key":"9448_CR153","doi-asserted-by":"publisher","first-page":"19S","DOI":"10.1016\/0002-9343(89)90109-5","volume":"87","author":"PB Corr","year":"1989","unstructured":"Corr PB, Heathers GP, Yamada KA. Mechanisms contributing to the arrhythmogenic influences of alpha 1-adrenergic stimulation in the ischemic heart. Am J Med. 1989;87(2A):19S\u201325S.","journal-title":"Am J Med"},{"issue":"3","key":"9448_CR154","doi-asserted-by":"publisher","first-page":"H1289","DOI":"10.1152\/ajpheart.00811.2005","volume":"290","author":"Vernat J. Exil","year":"2006","unstructured":"Exil VJ, Gardner CD, Rottman JN, Sims H, Bartelds B, Khuchua Z, et al. Abnormal mitochondrial bioenergetics and heart rate dysfunction in mice lacking very-long-chain acyl-CoA dehydrogenase. Am J Physiol Heart Circ Physiol. 2006;290(3):H1289\u201397.","journal-title":"American Journal of Physiology-Heart and Circulatory Physiology"},{"key":"9448_CR155","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.ymgmr.2018.03.007","volume":"15","author":"K Watanabe","year":"2018","unstructured":"Watanabe K, et al. Two siblings with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency suffered from rhabdomyolysis after l-carnitine supplementation. Mol Genet Metab Rep. 2018;15:121\u20133.","journal-title":"Mol Genet Metab Rep"},{"issue":"9","key":"9448_CR156","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1111\/j.1468-1331.2006.01482.x","volume":"13","author":"C Angelini","year":"2006","unstructured":"Angelini C, et al. Task force guidelines handbook: EFNS guidelines on diagnosis and management of fatty acid mitochondrial disorders. Eur J Neurol. 2006;13(9):923\u20139.","journal-title":"Eur J Neurol"},{"issue":"5","key":"9448_CR157","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s10545-009-9001-1","volume":"33","author":"B Wilcken","year":"2010","unstructured":"Wilcken B. Fatty acid oxidation disorders: outcome and long-term prognosis. J Inherit Metab Dis. 2010;33(5):501\u20136.","journal-title":"J Inherit Metab Dis"},{"issue":"5","key":"9448_CR158","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1007\/s10545-009-9000-2","volume":"33","author":"AM Lund","year":"2010","unstructured":"Lund AM, et al. Clinical and biochemical monitoring of patients with fatty acid oxidation disorders. J Inherit Metab Dis. 2010;33(5):495\u2013500.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"9448_CR159","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1093\/cvr\/cvt212","volume":"100","author":"AJ Bakermans","year":"2013","unstructured":"Bakermans AJ, et al. Myocardial energy shortage and unmet anaplerotic needs in the fasted long-chain acyl-CoA dehydrogenase knockout mouse. Cardiovasc Res. 2013;100(3):441\u20139.","journal-title":"Cardiovasc Res"},{"issue":"2\u20133","key":"9448_CR160","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1007\/s10545-006-0290-3","volume":"29","author":"CR Roe","year":"2006","unstructured":"Roe CR, Mochel F. Anaplerotic diet therapy in inherited metabolic disease: therapeutic potential. J Inherit Metab Dis. 2006;29(2\u20133):332\u201340.","journal-title":"J Inherit Metab Dis"},{"issue":"6","key":"9448_CR161","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1007\/s10545-017-0085-8","volume":"40","author":"MB Gillingham","year":"2017","unstructured":"Gillingham MB, et al. Triheptanoin versus trioctanoin for long-chain fatty acid oxidation disorders: a double blinded, randomized controlled trial. J Inherit Metab Dis. 2017;40(6):831\u201343.","journal-title":"J Inherit Metab Dis"},{"issue":"3","key":"9448_CR162","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.ymgme.2016.08.008","volume":"119","author":"J Vockley","year":"2016","unstructured":"Vockley J, et al. Triheptanoin treatment in patients with pediatric cardiomyopathy associated with long chain-fatty acid oxidation disorders. Mol Genet Metab. 2016;119(3):223\u201331.","journal-title":"Mol Genet Metab"},{"issue":"2","key":"9448_CR163","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1172\/JCI0215311","volume":"110","author":"CR Roe","year":"2002","unstructured":"Roe CR, et al. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest. 2002;110(2):259\u201369.","journal-title":"J Clin Invest"},{"key":"9448_CR164","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1750-1172-9-79","volume":"9","author":"V Aires","year":"2014","unstructured":"Aires V, et al. Stilbenes and resveratrol metabolites improve mitochondrial fatty acid oxidation defects in human fibroblasts. Orphanet J Rare Dis. 2014;9:79.","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"9448_CR165","doi-asserted-by":"publisher","first-page":"2048","DOI":"10.1093\/hmg\/ddr089","volume":"20","author":"J Bastin","year":"2011","unstructured":"Bastin J, Lopes-Costa A, Djouadi F. Exposure to resveratrol triggers pharmacological correction of fatty acid utilization in human fatty acid oxidation-deficient fibroblasts. Hum Mol Genet. 2011;20(10):2048\u201357.","journal-title":"Hum Mol Genet"},{"key":"9448_CR166","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s10545-016-9939-8","volume":"39","author":"JC Bleeker","year":"2016","unstructured":"Bleeker JC, Houtkooper RH. Sirtuin activation as a therapeutic approach against inborn errors of metabolism. J Inherit Metab Dis. 2016;39:565\u201372.","journal-title":"J Inherit Metab Dis"},{"issue":"18","key":"9448_CR167","doi-asserted-by":"publisher","first-page":"2695","DOI":"10.1093\/hmg\/ddi303","volume":"14","author":"F Djouadi","year":"2005","unstructured":"Djouadi F, et al. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders. Hum Mol Genet. 2005;14(18):2695\u2013703.","journal-title":"Hum Mol Genet"},{"issue":"3","key":"9448_CR168","doi-asserted-by":"publisher","first-page":"1791","DOI":"10.1210\/jc.2004-1936","volume":"90","author":"F Djouadi","year":"2005","unstructured":"Djouadi F, et al. Peroxisome proliferator activated receptor delta (PPARdelta) agonist but not PPARalpha corrects carnitine palmitoyl transferase 2 deficiency in human muscle cells. J Clin Endocrinol Metab. 2005;90(3):1791\u20137.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"9448_CR169","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/clpt.2010.55","volume":"88","author":"JP Bonnefont","year":"2010","unstructured":"Bonnefont JP, et al. Long-term follow-up of bezafibrate treatment in patients with the myopathic form of carnitine palmitoyltransferase 2 deficiency. Clin Pharmacol Ther. 2010;88(1):101\u20138.","journal-title":"Clin Pharmacol Ther"},{"issue":"7","key":"9448_CR170","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1212\/WNL.0000000000000118","volume":"82","author":"MC Orngreen","year":"2014","unstructured":"Orngreen MC, et al. Bezafibrate in skeletal muscle fatty acid oxidation disorders: a randomized clinical trial. Neurology. 2014;82(7):607\u201313.","journal-title":"Neurology"},{"issue":"2","key":"9448_CR171","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1007\/s10545-014-9779-3","volume":"38","author":"MC Orngreen","year":"2015","unstructured":"Orngreen MC, Vissing J, Laforet P. No effect of bezafibrate in patients with CPTII and VLCAD deficiencies. J Inherit Metab Dis. 2015;38(2):373\u20134.","journal-title":"J Inherit Metab Dis"},{"issue":"9367","key":"9448_CR172","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1016\/S0140-6736(03)13105-4","volume":"361","author":"JL Hove Van","year":"2003","unstructured":"Van Hove JL, et al. D,L-3-hydroxybutyrate treatment of multiple acyl-CoA dehydrogenase deficiency (MADD). Lancet. 2003;361(9367):1433\u20135.","journal-title":"Lancet"},{"issue":"1","key":"9448_CR173","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/s10545-016-9997-y","volume":"40","author":"RC W\u00fcst","year":"2017","unstructured":"W\u00fcst RC, et al. Ketones and inborn errors of metabolism: old friends revisited. J Inherit Metab Dis. 2017;40(1):3\u20134.","journal-title":"J Inherit Metab Dis"},{"issue":"2","key":"9448_CR174","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.cmet.2016.07.010","volume":"24","author":"PJ Cox","year":"2016","unstructured":"Cox PJ, et al. Nutritional ketosis alters fuel preference and thereby endurance performance in athletes. Cell Metab. 2016;24(2):256\u201368.","journal-title":"Cell Metab"},{"key":"9448_CR175","unstructured":"Bleeker, J.C., et al., Ketonesters as a Possible Novel Therapeutic Option for Patients With Fatty Acid Oxidation Disorders [abstract]. Abstracts presented at the 13th international congress of inborn errors of metabolism - ICIEM 2017. JIEMS abstract nr. 508, 2017. 5: p. 2326409817722292."}],"container-title":["Reviews in Endocrine and Metabolic Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11154-018-9448-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-018-9448-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11154-018-9448-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,25]],"date-time":"2022-08-25T20:20:29Z","timestamp":1661458829000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11154-018-9448-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":175,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["9448"],"URL":"https:\/\/doi.org\/10.1007\/s11154-018-9448-1","relation":{},"ISSN":["1389-9155","1573-2606"],"issn-type":[{"value":"1389-9155","type":"print"},{"value":"1573-2606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"20 June 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest related to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}